MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$131,120K
EPS
-$3.05
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
108,448
General and administrative
34,451
Total operating expenses
142,899
(loss) income from operations
-142,899
Interest and other income, net
11,779
(loss) income before income tax expense
-131,120
Net (loss) income
-131,120
Basic EPS
-3.05
Diluted EPS
-3.05
Basic Average Shares
42,976,024
Diluted Average Shares
42,976,024
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net (loss) income-$131,120K (loss) income beforeincome tax expense-$131,120K Interest and otherincome, net$11,779K (loss) income fromoperations-$142,899K Total operatingexpenses$142,899K Research and development$108,448K General andadministrative$34,451K

Maze Therapeutics, Inc. (MAZE)

Maze Therapeutics, Inc. (MAZE)